These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

371 related articles for article (PubMed ID: 28597879)

  • 1. To cage or to be caged? The cytotoxic species in ruthenium-based photoactivated chemotherapy is not always the metal.
    Cuello-Garibo JA; Meijer MS; Bonnet S
    Chem Commun (Camb); 2017 Jun; 53(50):6768-6771. PubMed ID: 28597879
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A mitochondria-targeting dinuclear Ir-Ru complex as a synergistic photoactivated chemotherapy and photodynamic therapy agent against cisplatin-resistant tumour cells.
    Zhang C; Guan R; Liao X; Ouyang C; Rees TW; Liu J; Chen Y; Ji L; Chao H
    Chem Commun (Camb); 2019 Oct; 55(83):12547-12550. PubMed ID: 31576841
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A nuclear permeable Ru(ii)-based photoactivated chemotherapeutic agent towards a series of cancer cells: in vitro and in vivo studies.
    Tian N; Feng Y; Sun W; Lu J; Lu S; Yao Y; Li C; Wang X; Zhou Q
    Dalton Trans; 2019 May; 48(19):6492-6500. PubMed ID: 30994660
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Photophysical Properties and Photobiological Activities of Ruthenium(II) Complexes Bearing π-Expansive Cyclometalating Ligands with Thienyl Groups.
    McCain J; Colón KL; Barrett PC; Monro SMA; Sainuddin T; Roque Iii J; Pinto M; Yin H; Cameron CG; McFarland SA
    Inorg Chem; 2019 Aug; 58(16):10778-10790. PubMed ID: 31386351
    [TBL] [Abstract][Full Text] [Related]  

  • 5. π-Expansive Heteroleptic Ruthenium(II) Complexes as Reverse Saturable Absorbers and Photosensitizers for Photodynamic Therapy.
    Wang L; Yin H; Jabed MA; Hetu M; Wang C; Monro S; Zhu X; Kilina S; McFarland SA; Sun W
    Inorg Chem; 2017 Mar; 56(6):3245-3259. PubMed ID: 28263079
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Strong Influence of Ancillary Ligands Containing Benzothiazole or Benzimidazole Rings on Cytotoxicity and Photoactivation of Ru(II) Arene Complexes.
    Lari M; Martínez-Alonso M; Busto N; Manzano BR; Rodríguez AM; Acuña MI; Domínguez F; Albasanz JL; Leal JM; Espino G; García B
    Inorg Chem; 2018 Nov; 57(22):14322-14336. PubMed ID: 30379535
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improving Cytotoxicity against Breast Cancer Cells by Using Mixed-Ligand Ruthenium(II) Complexes of 2,2'-Bipyridine, Amino Acid, and Nitric Oxide Derivatives as Potential Anticancer Agents.
    Gaspari APS; da Silva RS; Carneiro ZA; de Carvalho MR; Carvalho I; Pernomian L; Ferreira LP; Ramos LCB; de Souza GA; Formiga ALB
    Anticancer Agents Med Chem; 2021; 21(12):1602-1611. PubMed ID: 33081686
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Development of Ru(II)-Based Photoactivated Chemotherapy Agents.
    Chen Y; Bai L; Zhang P; Zhao H; Zhou Q
    Molecules; 2021 Sep; 26(18):. PubMed ID: 34577150
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Catch and Release Photosensitizers: Combining Dual-Action Ruthenium Complexes with Protease Inactivation for Targeting Invasive Cancers.
    Arora K; Herroon M; Al-Afyouni MH; Toupin NP; Rohrabaugh TN; Loftus LM; Podgorski I; Turro C; Kodanko JJ
    J Am Chem Soc; 2018 Oct; 140(43):14367-14380. PubMed ID: 30278123
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ruthenium Complexes as Anticancer Agents: A Brief History and Perspectives.
    Lee SY; Kim CY; Nam TG
    Drug Des Devel Ther; 2020; 14():5375-5392. PubMed ID: 33299303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Strained ruthenium complexes are potent light-activated anticancer agents.
    Howerton BS; Heidary DK; Glazer EC
    J Am Chem Soc; 2012 May; 134(20):8324-7. PubMed ID: 22553960
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytotoxic Ruthenium(II) Complexes Containing a Dangling Pyridine: Selectivity for Diseased Cells Mediated by pH-Dependent DNA Binding.
    Sangeetha S; Murali M
    Inorg Chem; 2022 Feb; 61(6):2864-2882. PubMed ID: 35099196
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A photoactivatable chemotherapeutic Ru(II) complex bearing bathocuproine ligand efficiently induces cell death in human malignant melanoma cells through a multi-mechanistic pathway.
    Elias MG; Mehanna S; Elias E; Khnayzer RS; Daher CF
    Chem Biol Interact; 2021 Oct; 348():109644. PubMed ID: 34508709
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Half-Sandwich Iridium(III) and Ruthenium(II) Complexes Containing P^P-Chelating Ligands: A New Class of Potent Anticancer Agents with Unusual Redox Features.
    Li J; Tian M; Tian Z; Zhang S; Yan C; Shao C; Liu Z
    Inorg Chem; 2018 Feb; 57(4):1705-1716. PubMed ID: 29400963
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detailed account on activation mechanisms of ruthenium coordination complexes and their role as antineoplastic agents.
    Pal M; Nandi U; Mukherjee D
    Eur J Med Chem; 2018 Apr; 150():419-445. PubMed ID: 29547831
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design of a Tris-Heteroleptic Ru(II) Complex with Red-Light Excitation and Remarkably Improved Photobiological Activity.
    Li S; Zhao J; Wang X; Xu G; Gou S; Zhao Q
    Inorg Chem; 2020 Aug; 59(15):11193-11204. PubMed ID: 32702972
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The anti-cancer effect of series of strained photoactivatable Ru(II) polypyridyl complexes on non-small-cell lung cancer and triple negative breast cancer cells.
    Fayad C; Audi H; Khnayzer RS; Daher CF
    J Biol Inorg Chem; 2021 Feb; 26(1):43-55. PubMed ID: 33221954
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Photosensitive Ru(II) Complexes as Inhibitors of the Major Human Drug Metabolizing Enzyme CYP3A4.
    Toupin N; Steinke SJ; Nadella S; Li A; Rohrabaugh TN; Samuels ER; Turro C; Sevrioukova IF; Kodanko JJ
    J Am Chem Soc; 2021 Jun; 143(24):9191-9205. PubMed ID: 34110801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Luminescent naphthalimide-tagged ruthenium(ii)-arene complexes: cellular imaging, photocytotoxicity and transferrin binding.
    Srivastava P; Verma M; Kumar A; Srivastava P; Mishra R; Sivakumar S; Patra AK
    Dalton Trans; 2021 Mar; 50(10):3629-3640. PubMed ID: 33625414
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ruthenium Complexes are pH-Activated Metallo Prodrugs (pHAMPs) with Light-Triggered Selective Toxicity Toward Cancer Cells.
    Qu F; Park S; Martinez K; Gray JL; Thowfeik FS; Lundeen JA; Kuhn AE; Charboneau DJ; Gerlach DL; Lockart MM; Law JA; Jernigan KL; Chambers N; Zeller M; Piro NA; Kassel WS; Schmehl RH; Paul JJ; Merino EJ; Kim Y; Papish ET
    Inorg Chem; 2017 Jul; 56(13):7519-7532. PubMed ID: 28636344
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.